Clinical Trial Update: Identification of Acute Intermittent Porphyria Modifying Genes

View source ↗

Summary

A clinical trial is investigating genetic modifiers that influence Acute Intermittent Porphyria, currently recruiting with Icahn School of Medicine at Mount Sin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Porphyria

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Acute Intermittent Porphyria (AIP) | Status: RECRUITING